Treace Medical Concepts (TMCI) Short term Debt (2020 - 2026)
Treace Medical Concepts posted quarterly Short term Debt of $1.8 million for Q1 2026, up 3846.67% year-on-year from $45000.0 in Q1 2025, and up 1.78% on a QoQ basis from $1.7 million in Q4 2025.
Treace Medical Concepts (TMCI) has 3 years of Short term Debt data on file, last reported at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Short term Debt rose 3846.67% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 3846.67% YoY), and the FY2025 full-year result was $1.7 million, changed N/A from the prior year.
- Short term Debt for Q1 2026 stood at $1.8 million, up from $1.7 million in the prior quarter.
- Across five years, Short term Debt topped out at $1.8 million in Q3 2025 and bottomed at $45000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Treace Medical Concepts | 234.79 Mn | 182.94 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2020 | 1.79 Mn |